Mar 15 2023

Delaware Senate Committee Approves Bills to Legalize Marijuana Including Retail Outlets

Two bills that would legalize marijuana possession and establish a regulated system of licensed retail outlets has been approved by a key Senate committee.

The Senate Health & Social Services Committee gave approval today to House Bill 1 and House Bill 2, both filed by State Representative Ed Osienksi in the House and sponsored by Senator Trey Paradee in the Senate. The measure now moves closer to a vote by the full Senate, where passage would put it before Governor John Carney. Representative Osienski says he’s “optimistic” that even if the governor were to veto the bills, the legislature would override the veto which it can do with a 2/3rds majority.

House Bill 2 passed the full House earlier this month by a vote of 27 to 13, which was almost identical to the 28 to 13 vote on House Bill 1.
Continue reading

Mar 15 2023

Arkansas: $22.4 Million in Medical Marijuana Sold in February

In Arkansas there was over $22 million dollars worth of marijuana and marijuana products purchased by authorized medical marijuana patients in February.

According to data released by the Arkansas Department of Finance and Administration, there was $22.4 million worth of medical marijuana products purchased in February, a slight decrease from the month prior (of course February had less days than January). In January there was $23.1 million in medical marijuana sold.

In total so far in 2023 Arkansas medical marijuana patients have purchased $45.5 million worth of the medicine, a 9.6% increase from the same period in 2022.
Continue reading

Mar 14 2023

Study Finds Cannabigerol (CBG) “Promising for Developing a Transdermal Dosage for Pain Management”

The cannabis compound cannabigerol (CBG) may be useful in combatting pain, according to new research published in the recent issue of the journal Biomedicine & Pharmacotherapy

As noted by the study’s abstract, the antinociceptive activity of tetrahydrocannabinol (THC) or cannabidiol (CBD) has been widely studied. However, “the antinociceptive effects of other cannabis components, such as cannabichromene (CBC) and cannabigerol (CBG), have rarely been revealed.”

With this in mind, researchers “investigated the antinociceptive effect of CBG on different pain models, and explored the mechanism of action of CBG to exert antinociceptive effects.”
Continue reading

Mar 14 2023

$18 Million in Marijuana Sold During First Month of Legal Sales in Connecticut

February marked the first full month of legal recreational marijuana sales in Connecticut.

According to data released by the Connecticut Department of Consumer Protection, licensed marijuana and medical marijuana retail outlets sold $18.4 million in marijuana and marijuana products to consumers in the month of February. Legal sales officially began on January 10, seven months after the state legalized marijuana.

In total the state sold $7.02 million in recreational marijuana from February 1 through February 28, while medical marijuana sales reached $11.4 million. In January sales for recreational marijuana were $5.1 billion, and $8 billion for medical marijuana.
Continue reading

Mar 14 2023

Kentucky Senate Committee Approves Bill to Legalize Medical Marijuana

For the first time ever a Senate committee in Kentucky has passed legislation that would legalize medical marijuana

The Senate Licensing & Occupations Committee voted 8 to 3 today to pass Senate Bill 47, filed by Senator Steve West with a bipartisan coalition of 13 cosponsors. The measure will now be sent to the full Senate, where passage would put it before the House which passed similar measures in 2020 and 2022 that stalled in the Senate.

In past years Senate Majority Floor Leader Damon Thayer has stood in the way of medical marijuana bills advancing in the Senate, but he now says that if the bill has enough votes to pass he won’t prevent it from advancing to the House.
Continue reading

Mar 13 2023

For First Time a Bill to Legalize Medical Marijuana Will Receive a Hearing in the Kentucky Senate

Legislation to make Kentucky the 40th state to legalize medical marijuana will receive a hearing in its first Senate committee on Thursday.

Senate Bill 47, filed by Senator Steve West with a bipartisan coalition of 13 cosponsors, will receive a hearing Thursday in the Senate Licensing & Occupations Committee. This marks the first time that any Senate committee has held an official hearing on a bill that would make medical marijuana legal. This is despite the fact that the House of Representatives passed a similar measure in 2020 and 2022.

“I believe we have enough votes to get this passed”  Senator Steve West told us. “It’s a big deal that we’re even having a hearing.”
Continue reading

Mar 13 2023

Washington State Collected Over $500 Million in Marijuana Taxes in 2022, Nearly Double Liquor Taxes

Washington State collected a total of $511.1 million in taxes from the legal marijuana industry in fiscal year 2022.

washington state Marijuana TaxesThis is according to the Liquor and Cannabis Control Board’s FY 2022 Annual Report. The report shows that the taxes garnered from marijuana sales were $251.2 million more than that of liquor sales. The marijuana tax revenue for fiscal year 2022 was nearly $50 million more than the previous fiscal year. The state made an additional $4.1 million in 2022 from marijuana licensing fees.

Revenues collected by the Liquor and Cannabis Board from legal cannabis taxes, license fees, and penalties are distributed as follow, according to the report:
Continue reading

Mar 13 2023

Canada’s Cannabis Legalization Has Not Impacted Motor Vehicle and Pedestrian/Cyclist Injuries

A study published by the peer-reviewed journal Addiction has found that there “were no statistically significant changes in rates of emergency department visits and hospitalizations for motor vehicle or pedestrian/cyclist injury” following Canada legalizing marijuana.

Titled The effect of recreational cannabis legalization on rates of traffic injury in Canada, the study was published by researchers at St. Michael’s Hospital, the University of Toronto and the Toronto Centre for Addiction and Mental Health.

The aim of the study was to “measure the impact of Canada’s recreational cannabis legalization (RCL) in October 2018 and the subsequent impact of the COVID-19 lockdowns from March 2020 on rates of emergency department (ED) visits and hospitalizations for traffic injury.”
Continue reading

Mar 13 2023

A Single Dose of CBD “Positively Influences Measures of Stress in Dogs During Separation and Car Travel”, Finds Study

A single dose of cannabidiol (CBD) “positively influences measures of stress in dogs during separation and car travel”, according to a new study published by the journal Frontiers in Veterinary Science.

Conducted by researchers at the Waltham Petcare Science Institute at Waltham on the Wolds, the study is titled A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel. The full text of the study can be found by clicking here.

“Many dogs experience stress when separated from their caregivers, as well as when traveling in vehicles”, states the study. “Pet owners employ various approaches to managing these issues, from training, to giving medications and supplements, often with mixed results.”
Continue reading

Mar 12 2023

Study: Medical Marijuana Use Doubled Between 2013 and 2020

The use of medical marijuana in the United States more than doubled between the 7-year period of 2013 to 2020.

The study, published in the American Journal of Preventive Medicine, notes that cannabis use for medical purposes is legalized across 39 states and the District of Columbia. The objective “was to evaluate temporal trends and correlates of cannabis use for medical purposes in the US.” The study was conducted by researchers at Yale School of Medicine, the Connecticut Healthcare System and the University of Connecticut School of Medicine.

The study found that the prevalence of U.S. residents using cannabis for medical purposes “increased significantly from 1.2% in 2013-2014 to 2.5% in 2019-2020.”
Continue reading

Load more